1. Academic Validation
  2. OTUD5 Protects Dopaminergic Neurons by Promoting the Degradation of α-Synuclein in Parkinson's Disease Model

OTUD5 Protects Dopaminergic Neurons by Promoting the Degradation of α-Synuclein in Parkinson's Disease Model

  • Adv Sci (Weinh). 2024 Dec 25:e2406700. doi: 10.1002/advs.202406700.
Xiaomeng Song 1 Tengfei Liu 1 Lu Yu 1 Qiuran Ji 1 Xin Guo 1 Runzhe Zong 1 Yiquan Li 1 Gan Huang 1 Qidi Xue 1 Qingyi Fu 1 Bingyu Liu 2 3 Yi Zheng 2 3 Lin Chen 1 Chengjiang Gao 2 3 Huiqing Liu 1 4
Affiliations

Affiliations

  • 1 Department of Pharmacology, School of Basic Medical Sciences, Shandong University, Jinan, Shandong, 250012, P. R. China.
  • 2 Key Laboratory of Infection and Immunity of Shandong Province, School of Basic Medical Sciences, Shandong University, Jinan, Shandong, 250012, P. R. China.
  • 3 Department of Immunology, School of Basic Medical Sciences, Shandong University, Jinan, Shandong, 250012, P. R. China.
  • 4 Department of Rehabilitation Medicine, The Second Hospital, Shandong University, Jinan, Shandong, 250012, P. R. China.
Abstract

Defective clearance and accumulation of α-synuclein (α-Syn) is the key pathogenic factor in Parkinson's disease (PD). Recent studies emphasize the importance of E3 Ligases in regulating the degradation of α-Syn. However, the molecular mechanisms by which deubiquitinases regulate α-Syn degradation are scarcely studied. In this study, it is found that the protein levels of α-Syn are negatively regulated by ovarian tumor protease Deubiquitinase 5 (OTUD5) which protects dopaminergic (DA) neurons in the PD model. Mechanistically, OTUD5 promotes K63-linked polyubiquitination of α-Syn independent of its deubiquitinating Enzyme activity and mediates its endolysosomal degradation by recruiting the E3 Ligase neural precursor cell expressed developmentally downregulated 4 (NEDD4). Furthermore, OTUD5 conditional knockout in DA neurons results in more severe α-Syn related pathology and dyskinesia after injection of α-Syn preformed fibrils (PFF). Overall, the data unveil a novel mechanism to regulate the degradation of α-Syn and provide a new therapeutic strategy to alleviate DA neurodegeneration.

Keywords

deubiquitinase; endolysosomal pathway; nedd4; otud5; parkinson's disease; α‐synuclein.

Figures
Products